154 related articles for article (PubMed ID: 35978974)
1. Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: A cause of concern.
De Berardis D; Di Carlo F; Di Giannantonio M; Pettorruso M
World J Psychiatry; 2022 Jun; 12(6):773-778. PubMed ID: 35978974
[TBL] [Abstract][Full Text] [Related]
2. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
Troyer EA; Kohn JN; Hong S
Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.
Banerjee D; Viswanath B
Asian J Psychiatr; 2020 Dec; 54():102350. PubMed ID: 33271682
[TBL] [Abstract][Full Text] [Related]
4. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
5. Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19.
Thye AY; Law JW; Tan LT; Pusparajah P; Ser HL; Thurairajasingam S; Letchumanan V; Lee LH
Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053059
[TBL] [Abstract][Full Text] [Related]
6. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
[TBL] [Abstract][Full Text] [Related]
7. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric and Cognitive Sequelae of COVID-19.
Kumar S; Veldhuis A; Malhotra T
Front Psychol; 2021; 12():577529. PubMed ID: 33737894
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study.
Du Y; Zhao W; Du L; Liu J
Psychoradiology; 2021 Dec; 1(4):199-211. PubMed ID: 38666221
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric sequelae in COVID-19 survivors: A narrative review.
Putri C; Arisa J; Hananto JE; Hariyanto TI; Kurniawan A
World J Psychiatry; 2021 Oct; 11(10):821-829. PubMed ID: 34733644
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
Alonso-Lana S; Marquié M; Ruiz A; Boada M
Front Aging Neurosci; 2020; 12():588872. PubMed ID: 33192483
[TBL] [Abstract][Full Text] [Related]
12. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].
El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B
Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984
[TBL] [Abstract][Full Text] [Related]
13. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
[TBL] [Abstract][Full Text] [Related]
14. Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect?
Forero-Peña DA; Hernandez MM; Mozo Herrera IP; Collado Espinal IB; Páez Paz J; Ferro C; Flora-Noda DM; Maricuto AL; Velásquez VL; Camejo-Avila NA; Sordillo EM; Delgado-Noguera LA; Perez-Garcia LA; Morantes Rodríguez CG; Landaeta ME; Paniz-Mondolfi AE
J Med Virol; 2022 Mar; 94(3):1154-1161. PubMed ID: 34755347
[TBL] [Abstract][Full Text] [Related]
15. RNA Coronaviruses' Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics.
Suaifan GARY; Alkhawaja BA; Mohammed AAM
Mini Rev Med Chem; 2022; 22(4):617-628. PubMed ID: 33888048
[TBL] [Abstract][Full Text] [Related]
16. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
17. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
18. Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019.
Andrabi MS; Andrabi SA
Front Pharmacol; 2020; 11():570031. PubMed ID: 33613275
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
Ahmed H; Patel K; Greenwood DC; Halpin S; Lewthwaite P; Salawu A; Eyre L; Breen A; O'Connor R; Jones A; Sivan M
J Rehabil Med; 2020 May; 52(5):jrm00063. PubMed ID: 32449782
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions.
Han Y; Yuan K; Wang Z; Liu WJ; Lu ZA; Liu L; Shi L; Yan W; Yuan JL; Li JL; Shi J; Liu ZC; Wang GH; Kosten T; Bao YP; Lu L
Transl Psychiatry; 2021 Sep; 11(1):499. PubMed ID: 34593760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
